Physician

Haysam Akkad, MD

According to 2025 Medicare claims, Haysam Akkad, MD (NPI: 1013997741) practices cardiology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is HAYSAM AKKAD, MD, PC (NPI: 1023258795; TIN: 263779733) and primary practice location at 68131-2858. Akkad is affiliated with the Nebraska Health Network, LLC (ACO ID: A3273), Caravan Health ACO 50 LLC (ACO ID: A5160), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Akkad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,235 traditional Medicare patients, billed 11,862 HCPCS/CPT codes, and received $738,594 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 11,639 prescription claims across 1,685 beneficiaries totaling $1,501,293 in drug costs, led by Eliquis (Apixaban). 2019 DME data shows 24 claims. Open Payments data shows 2 records totaling $60. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,145,628 to $738,594. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $438,926 to $1,501,293. For DME billing, this smaller-volume category fell sharply in recent years, from $3,499 to $1,237.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	3,585	17,680	$1,145,628
2016	3,717	18,207	$1,252,870
2017	3,928	18,822	$1,325,843
2018	3,816	19,662	$1,338,761
2019	3,682	17,246	$1,255,435
2020	2,735	14,269	$1,101,288
2021	2,473	13,228	$1,149,123
2022	2,315	11,348	$1,013,232
2023	2,334	11,613	$824,922
2024	2,235	11,862	$738,594

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,020	9,563	$438,926
2016	1,109	9,913	$539,941
2017	1,241	10,483	$581,802
2018	1,353	10,238	$687,649
2019	1,518	10,735	$888,652
2020	1,528	11,191	$1,169,935
2021	1,642	11,546	$1,323,724
2022	1,644	11,917	$1,525,401
2023	1,628	11,204	$1,488,026
2024	1,685	11,639	$1,501,293

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	17	$1,369
2016	N/R	14	$1,142
2017	N/R	N/R	N/R
2018	N/R	24	$1,076
2019	N/R	24	$1,355
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	471	472	$303
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	598	620	$105
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,764	3,851	$61
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	469	471	$46
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	931	1,357	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	1,055	53,921	$1,036,044
Xarelto	Rivaroxaban	165	10,791	$197,668
Entresto	Sacubitril/Valsartan	74	4,048	$80,657
Metoprolol Succinate	Metoprolol Succinate	1,958	127,827	$25,058
Brilinta	Ticagrelor	18	1,140	$16,429

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$60	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Haysam Akkad, MD?

Tedicare shows public-source Medicare data for Haysam Akkad, MD (NPI 1013997741), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Haysam Akkad, MD have ACO affiliation data?

Haysam Akkad, MD is shown with ACO affiliation data for Nebraska Health Network, LLC (MSSP, ACO ID A3273), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Haysam Akkad, MD?

Haysam Akkad, MD is linked to HAYSAM AKKAD, MD, PC (billing NPI 1023258795) in the available physician profile data.

Does Haysam Akkad, MD have Open Payments data?

Haysam Akkad, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.